Skip to main content
. Author manuscript; available in PMC: 2008 Jul 2.
Published in final edited form as: Drug Metab Dispos. 2007 Mar 7;35(6):973–980. doi: 10.1124/dmd.107.014779

Fig. 2.

Fig. 2

Kinetic characterization of CBR1 V88 and CBR1 I88 with the substrates daunorubicin (A) and prostaglandin E2 (B). Each point represents the mean ± S.D. of four experiments performed in duplicates with two independent protein preparations. Differences between curves were significant at p < 0.05 (A) and p < 0.01 (B).